Commitment to Patient Access and Affordability of Our Medicines

Our duty to put life-saving medicines in the hands of patients goes well beyond responsible launch pricing and limited list price increases. We have built a suite of novel and comprehensive patient programs to eliminate cost barriers for patients.

As part of our commitment to society, we have a special obligation to address the pressing financial issues that can prevent patients from getting the medicines they need. That’s why Sanofi continues to invest in our innovative and industry-leading savings programs that directly lower out-of-pocket costs for patients.

As a result of COVID-19, we also made temporary changes to our patient assistance programs, including permitting early reorder of prescriptions and extending our Temporary Patient Assistance Program from 90 to 180 days.

Every patient has unique circumstances, and no one should have to forego the medication they need because they can’t afford it. Sanofi has live support specialists at (800) 633-1610 to answer patients’ questions and help navigate their individual situations to find the best resources and programs to help lower their out-of-pocket costs.

2021 Patient Support: By The Numbers

2 million

# of times a Sanofi copay assistance card was used

$800 million

Patient savings from use of copay assistance programs

97,010

# of times Insulins Valyou Savings Program was used

$37 million

Patient savings from use of Insulins Valyou Savings Program

99,337

# of patients who received free medicine through patient assistance programs

$1.25 billion+

Value of medicine provided via patient assistance programs

MAT-US-2017362-v3.0-02/2022
Last Updated: February2022